- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 37.64M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $86.28M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $86.15M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $102M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $305M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.73B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $4.71B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $5.16B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $5.12B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 37.48M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.55M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $13.71M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $397.03M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $404.42M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.30 |
| Net Income | Q1 2025 · Mar 31, 2024 | $11.24M |
| Revenue | Q1 2025 · Mar 31, 2024 | $63.41M |